Vergoeding 2016-2020 voor ATC-subgroep N06AX : Overige antidepressiva
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| N06AX03 Mianserine | 83.922 | 58.727 | 38.853 | 41.462 | 25.007 |
| N06AX05 Trazodon (Trazolan ®) | 574.870 | 523.490 | 544.640 | 559.410 | 584.990 |
| N06AX11 Mirtazapine (Remeron ®) | 1.787.500 | 1.780.900 | 1.545.500 | 1.519.800 | 1.527.300 |
| N06AX12 Bupropion (Wellbutrin ®) | 4.371.400 | 4.627.600 | 5.078.500 | 5.413.900 | 5.653.100 |
| N06AX16 Venlafaxine (Efexor ®) | 3.661.800 | 3.447.100 | 3.505.600 | 3.689.900 | 3.686.100 |
| N06AX21 Duloxetine (Cymbalta ®) | 4.567.500 | 3.274.800 | 2.972.700 | 1.740.100 | 1.788.700 |
| N06AX22 Agomelatine (Valdoxan ®) | 1.074.400 | 941.850 | 855.260 | 667.890 | 499.740 |
| N06AX26 Vortioxetine (Brintellix ®) | 639.430 | 824.260 | 1.066.000 | 1.377.100 | 1.530.500 |
| Totaal | 16.760.822 | 15.478.727 | 15.607.053 | 15.009.562 | 15.295.437 |